Steven Stein
Fortuna: 8 M $ al 31/05/2026
Fortuna: 8 M $ al 31/05/2026
Steven H. Stein ocupa el cargo de Director Médico y Vicepresidente Ejecutivo de Incyte Corp. El Dr. Stein también forma parte del consejo de administración de Kura Oncology, Inc. En su anterior carrera, el Dr. Stein fue Vicepresidente de Oncología Global en GlaxoSmithKline (Nueva Jersey), Vicepresidente Senior de Desarrollo Clínico y Asuntos Médicos en Novartis Oncology, Inc. y Vicepresidente Senior de Desarrollo Clínico y Asuntos Médicos en Novartis Pharmaceuticals Corp. El Dr. Stein se doctoró en la Universidad de Witwatersrand.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INCYTE CORPORATION 0,04 % | 06/05/2026 | 78.327 ( 0,04 % ) | 8 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INCYTE CORPORATION | Director Técnico/Científico/I+D | 02/03/2015 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultor / Asesor | - |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Director/Miembro de la Junta | 28/01/2026 |
| THESEUS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 14/02/2024 |
| KURA ONCOLOGY, INC. | Director/Miembro de la Junta | 01/05/2023 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/02/2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/02/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Repare Therapeutics, Inc.
Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.